Merck & Co., Inc. (MRK) Reports Promising Skin Cancer Trial Results for Keytruda and Personalized mRNA Vaccine

Baillie Gifford & Co, an independent investment management firm, released its third-quarter 2026 investor letter for “International Concentrated Growth Strategy”. A copy of the letter can be downloaded here. The strategy outperformed its benchmark in the third quarter of 2026, as strong company-specific developments in biotechnology and digital platforms helped offset weakness in parts of […]